Travere Therapeutics
TVTX
#4720
Rank
โ‚ฌ1.55 B
Marketcap
17,83ย โ‚ฌ
Share price
-0.54%
Change (1 day)
110.30%
Change (1 year)

EPS for Travere Therapeutics (TVTX)

EPS in 2023 (TTM): -4,27ย โ‚ฌ

According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -4,39ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -4,24ย โ‚ฌ a decrease over its 2021 EPS that were of -2,94ย โ‚ฌ.

EPS history for Travere Therapeutics from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-4,27ย โ‚ฌ0.74%
2022-4,24ย โ‚ฌ44.22%
2021-2,94ย โ‚ฌ-10.09%
2020-3,27ย โ‚ฌ-2.6%
2019-3,36ย โ‚ฌ36.22%
2018-2,47ย โ‚ฌ64.94%
2017-1,49ย โ‚ฌ20.31%
2016-1,24ย โ‚ฌ-135.46%
20153,50ย โ‚ฌ-175.68%
2014-4,63ย โ‚ฌ98.75%
2013-2,33ย โ‚ฌ1746.15%
2012-0,13ย โ‚ฌ1.34%
2011-0,12ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-0,97ย โ‚ฌ-77.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,26ย โ‚ฌ-94.03%๐Ÿ‡บ๐Ÿ‡ธ USA